NOTABLE TRANSACTIONS
Sichenzia Ross Friedman Ference LLP Represents Genius Brands International on $4.3M PIPE
Sichenzia Ross Friedman Ference LLP Represents Israeli Biotech Company Can-Fite Biopharma on $4.8M Registered Direct Offering of ADSs
Can-Fite BioPharma Ltd.
$4,800,000
Registered Direct Offering with Institutional Investors
ADSs
October 2015
Read MoreSichenzia Ross Friedman Ference LLP Represents ContraVir Pharmaceuticals, Inc. on $15 Million Public Offering of Common Stock and Warrants
ContraVir Pharmaceuticals, Inc.
$15,000,000
Public Offering
Common Stock & Warrants
October 2015
Read MoreSichenzia Ross Friedman Ference LLP Represents Rightscorp in $1.032M PIPE
Sichenzia Ross Friedman Ference LLP Represents OriginClear, Inc. in $1.5M Acquisition of Progressive Water Treatment, Inc.
OriginClear, Inc.
$1,500,000
Acquisition of Progressive Water Treatment
Series B Preferred Stock
October 2015
Read MoreSichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in $5.5M Registered Direct Offering and Private Placement
Amarantus BioScience Holdings, Inc.
$5,500,000
Registered Direct Offering and Private Placement
Series H Convertible Preferred Stock and Warrants & Debts and Warrants
October 2015
Read MoreSichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs
Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company
BiondVax Pharmaceuticals
$9,550,000
Initial Public Offering
Represented U.S. Underwriter on Israeli-American Transaction
ADSs & Warrants
May 2015
Read MoreSichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals on $2.5M Registered Direct Offering
DelMar Pharmaceuticals, Inc.
$2,500,000
Registered Direct Offering
Common Stock & Warrants
August 2015
Read MoreSichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock
